Superworth

Neogenomics shares outstanding NEO

Diluted shares outstanding, averaged over each quarter, from 2011.

Latest quarter, to Sep 30, 2026
128.6M
On a year earlier
+0.1%
more shares

Neogenomics had 128.6M diluted shares outstanding on average in Q3 FY26, the quarter to Sep 30, 2026.

That is about the same as a year earlier.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY2025128.6M+1%
FY2024127.2M+1%
FY2023125.9M+1%
FY2022124.7M+2%
FY2021122.6M+7%
FY2020114.7M+6%
FY2019107.8M+11%
FY201896.9M+9%
FY201788.6M+13%
FY201678.5M+29%
FY201560.9M−2%
FY201462.2M+16%
FY201353.6M+18%
FY201245.3M+0%
FY201145.3Mn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q3 FY26128.6M+0%
Q2 FY26130.8M+2%
Q1 FY26129.2M+1%
Q4 FY25128.6M+1%
Q3 FY25128.4M+1%
Q2 FY25127.9M+1%
Q1 FY25127.4M+1%
Q4 FY24127.2M+1%
Q3 FY24127M+1%
Q2 FY24126.4M+1%
Q1 FY24126.1M+1%
Q4 FY23125.9M+1%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Neogenomics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.